We are live on ! Find out more
GNCA

Genocea Biosciences, Inc.
GNCA

Delisted

GNCA was delisted on the 2nd of June, 2022.

Back to rankings

5 hedge funds and large institutions have $92K invested in Genocea Biosciences, Inc. in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

88% less funds holding

Funds holding: 40 → 5 (-35)

97% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 36

100% less capital invested

Capital invested by funds: $42.1M → $92K (-$42M)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
5
Holders Change
-35
Holders Change %
-87.5%
% of All Funds
0.08%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
1
Increased
–
Reduced
1
Closed
36
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Barclays
Barclays
United Kingdom
+$1

Top Sellers

Rank Fund Capital Flow
1
NMC
NEA Management Company
Maryland
-$13M
2
BI
BVF Inc
California
-$5.02M
3
CC
Commodore Capital
New York
-$3.85M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$3.22M
5
KCM
Kingdon Capital Management
New York
-$2.46M
Name Holding Trade Value Shares
Change 		Change in
Stake
Wells Fargo
26
Wells Fargo
California
– -$20K -16,463 Closed
Bank of New York Mellon
27
Bank of New York Mellon
New York
– -$20K -16,305 Closed
PCA
28
Personal Capital Advisors
California
– -$19K -15,000 Closed
WA
29
WealthTrust Axiom
Pennsylvania
– -$18K -15,000 Closed
CAAS
30
Capital Asset Advisory Services
Michigan
– -$15K -11,766 Closed
Two Sigma Advisers
31
Two Sigma Advisers
New York
– -$13K -10,000 Closed
Simplex Trading
32
Simplex Trading
Illinois
– -$3.36K -8,476 -94%
TRCT
33
Tower Research Capital (TRC)
New York
– -$7K -5,847 Closed
ACM
34
ACT Capital Management
Pennsylvania
– -$6K -5,000 Closed
First Manhattan
35
First Manhattan
New York
– -$3K -2,500 Closed
AWA
36
Artemis Wealth Advisors
New York
– -$1.42K -1,137 Closed
Federated Hermes
37
Federated Hermes
Pennsylvania
– -$1K -905 Closed
CSS
38
Cubist Systematic Strategies
Connecticut
– -$1K -900 Closed
CG
39
Cutler Group
California
– -$1K -900 Closed
Barclays
40
Barclays
United Kingdom
– +$1 +3 New
1
2

GNCA Hedge Fund Activity: Q2 2022 in Review

5 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Genocea Biosciences, Inc. (GNCA) for Q2 2022, worth a combined $92K — down 100% from $42.1M a quarter earlier.

Sellers outnumbered buyers: 36 funds closed out of GNCA and 1 opened new positions — a net loss of 35 holders — while 1 trimmed existing stakes and 0 added.

The largest buyer was Barclays, opening a new position worth an estimated $1. The largest seller was NEA Management Company, exiting entirely with an estimated $13M sold.

  • 5 institutional investors held Genocea Biosciences, Inc. (GNCA) as of Q2 2022, down from 40 in Q1 2022.
  • Funds reported $92K of Genocea Biosciences, Inc. stock for Q2 2022, down 100% quarter-over-quarter.
  • 1 fund opened new Genocea Biosciences, Inc. positions in Q2 2022 and 36 closed out, a net change of -35 holders.
  • The largest Genocea Biosciences, Inc. buyer in Q2 2022 was Barclays, an estimated $1 added.
  • The largest Genocea Biosciences, Inc. seller in Q2 2022 was NEA Management Company, an estimated $13M sold.

Based on aggregated 13F filings for Q2 2022.